IMCERA'S MALLINCKRODT MEDICAL UNIT AND ADVANCED WARMING SYSTEMS SIGN AGREEMENT ON PATIENT HYPOTHERMIA SYSTEM
IMCERA'S MALLINCKRODT MEDICAL UNIT AND ADVANCED WARMING
SYSTEMS SIGN AGREEMENT ON PATIENT HYPOTHERMIA SYSTEM
NORTHBROOK, Ill., Jan. 6 /PRNewswire/ -- IMCERA Group Inc. (NYSE: IMA) announced today that its Mallinckrodt Medical unit of St. Louis has signed an exclusive, worldwide licensing agreement with Advanced Warming Systems, Inc., of Lubbock, Texas, to manufacture and distribute a new warming system designed to treat hypothermia in surgical and critical care patients. Terms of the agreement were not disclosed.
Advanced Warming Systems is a research and product development company specializing in advanced technology to prevent and treat hypothermia. The new warming system, called "WarmTouch," is its first commercial product.
Scheduled for introduction in the spring of 1992, the system consists of a warming unit which filters and circulates warm air into a blanket-type device placed over or under a patient. The air temperature and flow rate are controlled to maintain patient comfort and temperature which helps speed the recovery process.
Hypothermia is an abnormally low body temperature which exists when core body temperature falls below 36 degrees centigrade (96.8 degrees Fahrenheit). Approximately 70 percent of all post-operative patients, or 14 million patients annually in the U.S. alone, are hypothermic. It is expected that the world market for the warming device could exceed $50 million in the next several years.
The WarmTouch system will be produced and distributed exclusively by Mallinckrodt Anesthesiology, a division of Mallinckrodt Medical which produces tracheal tubes, temperature monitoring systems and related products used in anesthesiology and critical care.
Mallinckrodt Anesthesiology and Advanced Warming Systems plan on entering an additional, collaborative R&D agreement for development of other patient warming and anesthesiology related products.
"This new product will complement our world leadership position in continuous core temperature monitoring systems," said Chuck Clark, Mallinckrodt Medical vice president and general manager of anesthesiology. "We believe its cost-effective performance and innovative features will make the WarmTouch system very appealing to hospitals for hypothermia prevention and treatment."
Dr. Randall Hickle, founder and CEO of Advanced Warming Systems, said his company plans to become the market leader in advanced technology involving hypothermia products.
"We are very excited about our relationship with Mallinckrodt Medical because this partnership will enable the WarmTouch system to be made available to patients worldwide," he said. "Hypothermia continues to be a serious concern in post-operative and other critical care patients. The WarmTouch system represents a significant advance in terms of improving patient comfort and care."
Dr. Hickle, who founded Advanced Warming Systems in 1989, is a practicing anesthesiologist specializing in cardiac, major vascular and thoracic anesthesia at Methodist Hospital and St. Mary's Hospital in Lubbock. The WarmTouch system has been successful with market tests in those two hospitals and has received U.S. Food and Drug Administration regulatory clearance for market introduction.
Mallinckrodt Medical, with fiscal 1991 net sales and operating earnings of $513 million and $87 million, respectively, also is a major supplier of products used in radiology, cardiology, nuclear medicine and other critical care procedures.
IMCERA, a Fortune 300 company with net sales of more than $1.6 billion in fiscal 1991, has two other international, technology-based businesses--Mallinckrodt Specialty Chemicals of Chesterfield, Mo.; and Pitman-Moore of Lake Forest, Ill.
/CONTACT: Dave Prichard, of IMCERA Group, 708-205-2270; or Patrick Griffin of Advanced Warming Systems, 806-796-1246/
(IMA) CO: IMCERA Group Inc.; Advanced Warming Systems Inc. ST: Illinois, Texas IN: MTC SU: SH -- NY031 -- 6860 01/06/92 11:24 EST